Key Drivers
- Stable Margins
- High Leverage
- Weak Cash Flow
AIAI Summary
SEM should be viewed primarily as a merger-arbitrage position around the $16.50 cash take-private, where the main upside is a clean closing and the main risk is that ongoing fairness scrutiny or litigation delays or jeopardizes the deal rather than any operating upside.
Price Chart
Financial Metrics
Deep Analysis
Research tool. Not personalized advice.
Fundamental Analysis
Key Financial Insights:
- •Stable Margins
- •High Leverage
- •Weak Cash Flow
SEM delivers consistent but modest margins at a reasonable valuation, yet high leverage, thin cash, and weaker free cash flow make the balance sheet the main risk.
Price Behavior
Key Price Behavior Insights:
- •Higher lows
- •Tight range
- •Near resistance
SEM has drifted slightly higher over the last month with steady higher lows and support at $16.33-$16.35, but the tight $16.37-$16.39 range and late test of $16.50 show only mild upside momentum unless it breaks resistance.
Mostly confined to a tight $16.37-$16.39 band, with only a late test of $16.50
Sentiment & News
Key News Insights:
- •Deal scrutiny
- •Earnings miss
- •Regulatory progress
Select Medical's late-April to mid-May updates were dominated by mounting shareholder scrutiny of its $16.50/share take-private deal, alongside a Q1 earnings miss and mixed operating performance despite some revenue strength.
The stock is likely to stay driven by takeover fairness debate and execution risk until the buyout process and operating trends become clearer
Similar Companies in Healthcare
Other companies in the same sector with AI ratings